Temasek Life Sciences Private Ltd, 10% Owner at VICAL INC (VICL), sold 65,248 shares at $2.75 ($171K) on 2009-05-21, disclosed to the SEC on 2009-05-22.
Open-market sale of $171k VICL by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.25 | 4,700 | $11K | 6.2% |
| 2 | $2.26 | 300 | $678 | 0.4% |
| 3 | $2.27 | 600 | $1K | 0.8% |
| 4 | $2.27 | 400 | $908 | 0.5% |
| 5 | $2.29 | 2,700 | $6K | 3.6% |
| 6 | $2.30 | 700 |
| $2K |
| 0.9% |
| 7 | $2.31 | 400 | $924 | 0.5% |
| 8 | $2.32 | 900 | $2K | 1.2% |
| 9 | $2.33 | 2,100 | $5K | 2.9% |
| 10 | $2.39 | 2,948 | $7K | 4.1% |
| 11 | $2.68 | 2,600 | $7K | 4.1% |
| 12 | $2.69 | 4,200 | $11K | 6.6% |
| 13 | $2.70 | 8,100 | $22K | 12.8% |
| 14 | $2.71 | 7,520 | $20K | 11.9% |
| 15 | $2.72 | 1,980 | $5K | 3.1% |
| 16 | $2.73 | 2,180 | $6K | 3.5% |
| 17 | $2.74 | 8,400 | $23K | 13.4% |
| 18 | $2.75 | 8,520 | $23K | 13.7% |
| 19 | $2.76 | 3,100 | $9K | 5.0% |
| 20 | $2.77 | 2,300 | $6K | 3.7% |
| 21 | $2.78 | 600 | $2K | 1.0% |
| Total | $2.62 avg | 65,248 | $171K | 100% |